Plasma CTGF is independently related to an increased risk of cardiovascular events and mortality in patients with atherosclerotic disease: the SMART study

References

• Accornero F, van Berlo JH, Correll RN, Elrod JW, Sargent MA, York A, Rabinowitz JE, et al. 2015. Genetic analysis of connective tissue growth factor as an effector of transforming growth factor beta signaling and cardiac remodeling. Mol Cell Biol 35:2154–2164
   PubMed Web of Science ®Google Scholar
• Behnes M, Brueckmann M, Lang S, Weiss C, Ahmad-Nejad P, Neumaier M, Borggrefe M, Hoffmann U. 2014. Connective tissue growth factor (CTGF/CCN2): Diagnostic and prognostic value in acute heart failure. Clin Res Cardiol 103:107–116
   PubMed Web of Science ®Google Scholar
• Casale PN, Devereux RB, Kligfield P, Eisenberg RR, Miller DH, Chaudhary BS, Phillips MC. 1985. Electrocardiographic detection of left ventricular hypertrophy: Development and prospective validation of improved criteria. J Am Coll Cardiol 6:572–580
   PubMed Web of Science ®Google Scholar
• Cheng O, Thuillier R, Sampson E, Schultz G, Ruiz P, Zhang X, Yuen PS, Mannon RB. 2006. Connective tissue growth factor is a biomarker and mediator of kidney allograft fibrosis. Am J Transplant 6:2292–2306
   PubMed Web of Science ®Google Scholar
• Cicha I, Goppelt-Struebe M. 2009. Connective tissue growth factor: Context-dependent functions and mechanisms of regulation. Biofactors 35:200–208
   PubMed Web of Science ®Google Scholar
• Cicha I, Goppelt-Struebe M, Muehlich S, Yilmaz A, Raaz D, Daniel WG, Garlichs CD. 2008. Pharmacological inhibition of RhoA signaling prevents connective tissue growth factor induction in endothelial cells exposed to non-uniform shear stress. Atherosclerosis 196:136–145
   PubMed Web of Science ®Google Scholar
• Cicha I, Yilmaz A, Klein M, Raithel D, Brigstock DR, Daniel WG, Goppelt-Struebe M, Garlichs CD. 2005. Connective tissue growth factor is overexpressed in complicated atherosclerotic plaques and induces mononuclear cell chemotaxis in vitro. Arterioscler Thromb Vasc Biol 25:1008–1013
   PubMed Web of Science ®Google Scholar
• Daniels A, van Bilsen M, Goldschmeding R, van der Vusse GJ, van Nieuwenhoven FA. 2009. Connective tissue growth factor and cardiac fibrosis. Acta Physiol (Oxf) 195:321–338
   PubMed Web of Science ®Google Scholar
• Den Hoedt CH, Gerritsen KG, Grooteman MP, Penne EL, Van der Weerd NC, Mazairac AH, Ter Wee PM, et al. 2012. Connective tissue growth factor is related to all cause mortality in hemodialysis patients and is lowered by on-line hemodiafiltration. Results from the CONvective TRAnsport STudy. In: Gerritsen K, Editor. Pharmacokinetics of connective tissue growth factor; Chapter 8. Enschede: Gildeprint Drukkerijen
   Google Scholar
• Dendooven A, Gerritsen KG, Nguyen TQ, Kok RJ, Goldschmeding R. 2011. Connective tissue growth factor (CTGF/CCN2) ELISA: A novel tool for monitoring fibrosis. Biomarkers 16:289–301
   PubMed Web of Science ®Google Scholar
• Fan WH, Pech M, Karnovsky MJ. 2000. Connective tissue growth factor (CTGF) stimulates vascular smooth muscle cell growth and migration in vitro. Eur J Cell Biol 79:915–923
   PubMed Web of Science ®Google Scholar
• Finckenberg P. 2003. Regulation of Connective Tissue Growth Factor (CTGF) in hypertension-induced end organ damage [E-Thesis]. University of Helsinki, 1–75
   Google Scholar
• Fontes MS, Kessler EL, van Stuijvenberg L, Brans MA, Falke LL, Kok B, Leask A, et al. 2015. CTGF knockout does not affect cardiac hypertrophy and fibrosis formation upon chronic pressure overload. J Mol Cell Cardiol 88:82–90
   PubMed Web of Science ®Google Scholar
• Gerritsen KG, Abrahams AC, Peters HP, Nguyen TQ, Koeners MP, den Hoedt CH, Dendooven A, et al. 2012. Effect of GFR on plasma N-terminal connective tissue growth factor (CTGF) concentrations. Am J Kidney Dis 59:619–627
   PubMed Web of Science ®Google Scholar
• Gomez-Garre D, Martin-Ventura JL, Granados R, Sancho T, Torres R, Ruano M, Garcia-Puig J, Egido J. 2006. Losartan improves resistance artery lesions and prevents CTGF and TGF-beta production in mild hypertensive patients. Kidney Int 69:1237–1244
   PubMed Web of Science ®Google Scholar
• Gravning J, Ahmed MS, von Lueder TG, Edvardsen T, Attramadal H. 2013. CCN2/CTGF attenuates myocardial hypertrophy and cardiac dysfunction upon chronic pressure-overload. Int J Cardiol 168:2049–2056
   PubMed Web of Science ®Google Scholar
• Huang J, Huang H, Wu M, Li J, Xie H, Zhou H, Liao E, Peng Y. 2013. Connective tissue growth factor induces osteogenic differentiation of vascular smooth muscle cells through ERK signaling. Int J Mol Med 32:423–429
   PubMed Web of Science ®Google Scholar
• Humphreys BD, Lin SL, Kobayashi A, Hudson TE, Nowlin BT, Bonventre JV, Valerius MT, et al. 2010. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol 176:85–97
   PubMed Web of Science ®Google Scholar
• Inoki I, Shiomi T, Hashimoto G, Enomoto H, Nakamura H, Makino K, Ikeda E, et al. 2002. Connective tissue growth factor binds vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis. Faseb J 16:219–221
   PubMedGoogle Scholar
• Ito Y, Aten J, Nguyen TQ, Joles JA, Matsuo S, Weening JJ, Goldschmeding R . 2011. Involvement of connective tissue growth factor in human and experimental hypertensive nephrosclerosis. Nephron Exp Nephrol 117:e9–20
   PubMed Web of Science ®Google Scholar
• Jaffa AA, Usinger WR, McHenry MB, Jaffa MA, Lipstiz SR, Lackland D, Lopes-Virella M, et al. 2008. Connective tissue growth factor and susceptibility to renal and vascular disease risk in type 1 diabetes. J Clin Endocrinol Metabol 93:1893–1900
   PubMed Web of Science ®Google Scholar
• Jedsadayanmata A, Chen CC, Kireeva ML, Lau LF, Lam SC. 1999. Activation-dependent adhesion of human platelets to Cyr61 and Fisp12/mouse connective tissue growth factor is mediated through integrin alpha(IIb)beta(3). J Biol Chem 274:24321–24327
   PubMed Web of Science ®Google Scholar
• Koitabashi N, Arai M, Niwano K, Watanabe A, Endoh M, Suguta M, Yokoyama T, et al. 2008. Plasma connective tissue growth factor is a novel potential biomarker of cardiac dysfunction in patients with chronic heart failure. Eur J Heart Fail 10:373–379
   PubMed Web of Science ®Google Scholar
• Koshman YE, Sternlicht MD, Kim T, O'Hara CP, Koczor CA, Lewis W, Seeley TW, et al. 2015. Connective tissue growth factor regulates cardiac function and tissue remodeling in a mouse model of dilated cardiomyopathy. J Mol Cell Cardiol 89:214–222
   PubMed Web of Science ®Google Scholar
• Lan TH, Huang XQ, Tan HM. 2013. Vascular fibrosis in atherosclerosis. Cardiovasc Pathol 22:401–407
   PubMed Web of Science ®Google Scholar
• Langsetmo I, Jacob CT, Zhang W, Oliver N, Lin A, Coker G, Liu DY. 2006. Anti-CTGF human antibody FG-3019 prevents and reverses diabetes-induced cardiovascular complications in streptozotocin (STZ) treated rats (Abstract). Diabetes 55:A122
   Google Scholar
• Lee YS, Byun J, Kim JA, Lee JS, Kim KL, Suh YL, Kim JM, et al. 2005. Monocrotaline-induced pulmonary hypertension correlates with upregulation of connective tissue growth factor expression in the lung. Exp Mol Med 37:27–35
   PubMed Web of Science ®Google Scholar
• Lee CH, Shah B, Moioli EK, Mao JJ. 2010. CTGF directs fibroblast differentiation from human mesenchymal stem/stromal cells and defines connective tissue healing in a rodent injury model. J Clin Invest 120:3340–3349
   PubMed Web of Science ®Google Scholar
• Leeuwis JW, Nguyen TQ, Theunissen MG, Peeters W, Goldschmeding R, Pasterkamp G, Vink A. 2010. Connective tissue growth factor is associated with a stable atherosclerotic plaque phenotype and is involved in plaque stabilization after stroke. Stroke 41:2979–2981
   PubMed Web of Science ®Google Scholar
• Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, Kusek JW, Van Lente F. 2006. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 145:247–254
   PubMed Web of Science ®Google Scholar
• Li C, Zhen G, Chai Y, Xie L, Crane JL, Farber E, Farber CR, et al. 2016. RhoA determines lineage fate of mesenchymal stem cells by modulating CTGF-VEGF complex in extracellular matrix. Nat Commun 7:11455
   PubMed Web of Science ®Google Scholar
• Nguyen TQ, Tarnow L, Jorsal A, Oliver N, Roestenberg P, Ito Y, Parving HH, et al. 2008. Plasma connective tissue growth factor is an independent predictor of end-stage renal disease and mortality in type 1 diabetic nephropathy. Diabetes Care 31:1177–1182
   PubMed Web of Science ®Google Scholar
• Ohnishi H, Oka T, Kusachi S, Nakanishi T, Takeda K, Nakahama M, Doi M, et al. 1998. Increased expression of connective tissue growth factor in the infarct zone of experimentally induced myocardial infarction in rats. J Mol Cell Cardiol 30:2411–2422
   PubMed Web of Science ®Google Scholar
• Panek AN, Posch MG, Alenina N, Ghadge SK, Erdmann B, Popova E, Perrot A, et al. 2009. Connective tissue growth factor overexpression in cardiomyocytes promotes cardiac hypertrophy and protection against pressure overload. PLoS One 4:e6743
   PubMed Web of Science ®Google Scholar
• Ponticos M. 2013. Connective tissue growth factor (CCN2) in blood vessels. Vascul Pharmacol 58:189–193
   PubMed Web of Science ®Google Scholar
• Poredos P. 2004. Intima-media thickness: Indicator of cardiovascular risk and measure of the extent of atherosclerosis. Vasc Med 9:46–54
   PubMed Web of Science ®Google Scholar
• Rickard AJ, Morgan J, Chrissobolis S, Miller AA, Sobey CG, Young MJ. 2014. Endothelial cell mineralocorticoid receptors regulate deoxycorticosterone/salt-mediated cardiac remodeling and vascular reactivity but not blood pressure. Hypertension 63:1033–1040
   PubMed Web of Science ®Google Scholar
• Rodrigues-Diez RR, Garcia-Redondo AB, Orejudo M, Rodrigues-Diez R, Briones AM, Bosch-Panadero E, Kery G, et al. 2015. The C-terminal module IV of connective tissue growth factor, through EGFR/Nox1 signaling, activates the NF-kappaB pathway and proinflammatory factors in vascular smooth muscle cells. Antioxid Redox Signal 22:29–47
   PubMed Web of Science ®Google Scholar
• Roestenberg P, van Nieuwenhoven FA, Joles JA, Trischberger C, Martens PP, Oliver N, Aten J, Wiersinga WM, et al. 2006. Temporal expression profile and distribution pattern indicate a role of connective tissue growth factor (CTGF/CCN-2) in diabetic nephropathy in mice. Am J Physiol Renal Physiol 290:F1344–F1354
   PubMed Web of Science ®Google Scholar
• Roestenberg P, van Nieuwenhoven FA, Wieten L, Boer P, Diekman T, Tiller AM, et al. 2004. Connective tissue growth factor is increased in plasma of type 1 diabetic patients with nephropathy. Diabetes Care 27:1164–1170
   PubMed Web of Science ®Google Scholar
• Ruiz-Ortega M, Rodriguez-Vita J, Sanchez-Lopez E, Carvajal G, Egido J. 2007. TGF-beta signaling in vascular fibrosis. Cardiovasc Res 74:196–206
   PubMed Web of Science ®Google Scholar
• Sanchez-Lopez E, Rayego S, Rodrigues-Diez R, Rodriguez JS, Rodriguez-Vita J, Carvajal G, Aroeira LS, et al. 2009. CTGF promotes inflammatory cell infiltration of the renal interstitium by activating NF-kappaB. J Am Soc Nephrol 20:1513–1526
   PubMed Web of Science ®Google Scholar
• Schober JM, Chen N, Grzeszkiewicz TM, Jovanovic I, Emeson EE, Ugarova TP, Ye RD, et al. 2002. Identification of integrin alpha(M)beta(2) as an adhesion receptor on peripheral blood monocytes for Cyr61 (CCN1) and connective tissue growth factor (CCN2): immediate-early gene products expressed in atherosclerotic lesions. Blood 99:4457–4465
   PubMed Web of Science ®Google Scholar
• Simons PC, Algra A, van de Laak MF, Grobbee DE, van der Graaf Y. 1999. Second manifestations of ARTerial disease (SMART) study: Rationale and design. Eur J Epidemiol 15:773–781
   PubMed Web of Science ®Google Scholar
• Slagman MC, Nguyen TQ, Waanders F, Vogt L, Hemmelder MH, Laverman GD, Goldschmeding R, Navis G. 2011. Effects of antiproteinuric intervention on elevated connective tissue growth factor (CTGF/CCN-2) plasma and urine levels in nondiabetic nephropathy. Clin J Am Soc Nephrol 6:1845–1850
   PubMed Web of Science ®Google Scholar
• Sohn M, Tan Y, Wang B, Klein RL, Trojanowska M, Jaffa AA. 2006. Mechanisms of low-density lipoprotein-induced expression of connective tissue growth factor in human aortic endothelial cells. Am J Physiol Heart Circ Physiol 290:H1624–H1634
   Google Scholar
• Sokolow M, Lyon TP. 2001. The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. 1949. Ann Noninvasive Electrocardiol 6:343–368
   PubMed Web of Science ®Google Scholar
• Stolk RP, Meijer R, Mali WP, Grobbee DE, van der Graaf Y. 2003. Ultrasound measurements of intraabdominal fat estimate the metabolic syndrome better than do measurements of waist circumference. Am J Clin Nutr 77:857–860
   PubMed Web of Science ®Google Scholar
• Syeda B, Gottsauner-Wolf M, Denk S, Pichler P, Khorsand A, Glogar D. 2003. Arterial compliance: A diagnostic marker for atherosclerotic plaque burden? Am J Hypertens 16:356–362
   PubMed Web of Science ®Google Scholar
• Szabo Z, Magga J, Alakoski T, Ulvila J, Piuhola J, Vainio L, Kivirikko KI, et al. 2014. Connective tissue growth factor inhibition attenuates left ventricular remodeling and dysfunction in pressure overload-induced heart failure. Hypertension 63:1235–1240
   PubMed Web of Science ®Google Scholar
• Tapp RJ, Shaw JE, Zimmet PZ, Balkau B, Chadban SJ, Tonkin AM, Welborn TA, Atkins RC. 2004. Albuminuria is evident in the early stages of diabetes onset: Results from the Australian diabetes, obesity, and lifestyle study (AusDiab). Am J Kidney Dis 44:792–798
   PubMed Web of Science ®Google Scholar
• van Dijk CG, Nieuweboer FE, Pei JY, Xu YJ, Burgisser P, van Mulligen E, el Azzouzi H, et al. 2015. The complex mural cell: Pericyte function in health and disease. Int J Cardiol 190:75–89
   PubMed Web of Science ®Google Scholar
• Van Geest RJ, Leeuwis JW, Dendooven A, Pfister F, Bosch K, Hoeben KA, Vogels IM, et al. 2014. Connective tissue growth factor is involved in structural retinal vascular changes in long-term experimental diabetes. J Histochem Cytochem 62:109–118
   PubMed Web of Science ®Google Scholar
• Wan M, Li C, Zhen G, Jiao K, He W, Jia X, Wang W, et al. 2012. Injury-activated transforming growth factor β controls mobilization of mesenchymal stem cells for tissue remodeling. Stem Cells 30:2498–2511
   PubMed Web of Science ®Google Scholar
• Watts KL, Spiteri MA. 2004. Connective tissue growth factor expression and induction by transforming growth factor-beta is abrogated by simvastatin via a Rho signaling mechanism. Am J Physiol Lung Cell Mol Physiol 287:L1323–L1332
   PubMedGoogle Scholar
• Weber KT, Brilla CG. 1993. Structural basis for pathologic left ventricular hypertrophy. Clin Cardiol 16:II10–II14
   PubMedGoogle Scholar
• Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. 1998. Prediction of coronary heart disease using risk factor categories. Circulation 97:1837–1847
   PubMed Web of Science ®Google Scholar
• Wolf G. 2006. Renal injury due to renin-angiotensin-aldosterone system activation of the transforming growth factor-beta pathway. Kidney Int 70:1914–1919
   PubMed Web of Science ®Google Scholar
• Yan LF, Wei YN, Nan HY, Yin Q, Qin Y, Zhao X, Chen BY, et al. 2014. Proliferative phenotype of pulmonary microvascular endothelial cells plays a critical role in the overexpression of CTGF in the bleomycin-injured rat. Exp Toxicol Pathol 66:61–71
   PubMed Web of Science ®Google Scholar
• Yang B, Hodgkinson AD, Shaw NA, Millward BA, Demaine AG. 2013. Protective effect of statin therapy on connective tissue growth factor induction by diabetes in vivo and high glucose in vitro. Growth Factors 31:199–208
   PubMed Web of Science ®Google Scholar
• Yoon PO, Lee MA, Cha H, Jeong MH, Kim J, Jang SP, Choi BY, et al. 2010. The opposing effects of CCN2 and CCN5 on the development of cardiac hypertrophy and fibrosis. J Mol Cell Cardiol 49:294–303
   PubMed Web of Science ®Google Scholar
• Yoshisue H, Suzuki K, Kawabata A, Ohya T, Zhao H, Sakurada K, Taba Y, et al. 2002. Large scale isolation of non-uniform shear stress-responsive genes from cultured human endothelial cells through the preparation of a subtracted cDNA library. Atherosclerosis 162:323–334
   PubMed Web of Science ®Google Scholar